<DOC>
	<DOC>NCT00420095</DOC>
	<brief_summary>The purpose of this study is to compare glycemic control (HbA1c) in Chinese patients with type 1 or type 2 diabetes when treated with insulin lispro low mixture and human insulin 30/70.</brief_summary>
	<brief_title>A Study for Patients With Diabetes Mellitus (IOPA)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Clinically diagnosed type 1or type 2 diabetes for at least 2 months Aged between 18 and 70 (inclusive) Have been treated with human insulin mix 30/70 twice daily for at least 2 months prior to entering the study Have glycosylated hemoglobin (Hb1Ac) between 1.2 and 1.7 times the upper limit of normal reference range within 2 weeks prior to or at Visit 1 Compliance with diet and insulin therapy and performs regular blood glucose monitoring Have used oral antidiabetic agents within 30 days prior to entry into the study Receive a total daily dose of insulin &gt;2 units/kilogram Have had more than two episodes of severe hypoglycemia within 6 months prior to entry into the study Have a body mass index &gt;35 kilograms per square meter (kg/m2) Receive chronic systemic glucocorticoid therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>diabetes</keyword>
	<keyword>type 1</keyword>
	<keyword>type 2</keyword>
</DOC>